of the Federal Food, Drug, and Cosmetic Act (FDCA).* Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Stay Legal Selling Peptides Online with 2025 Compliance Tips Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives